Your browser doesn't support javascript.
loading
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Huang, Quanfang; Bai, Facheng; Nie, Jinlan; Lu, Shengjuan; Lu, Chunyuang; Zhu, Xunshuai; Zhuo, Lang; Lin, Xing.
Affiliation
  • Huang Q; The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China.
  • Bai F; Guangxi Medical University, Nanning 530021, China.
  • Nie J; Guangxi Medical University, Nanning 530021, China.
  • Lu S; Guangxi Medical University, Nanning 530021, China.
  • Lu C; Guangxi Medical University, Nanning 530021, China.
  • Zhu X; Guangxi Medical University, Nanning 530021, China.
  • Zhuo L; Institute of Bioengineering and Nanotechnology, Singapore 169483, Singapore.
  • Lin X; Guangxi Medical University, Nanning 530021, China. Electronic address: gxLx60@163.com.
Int Immunopharmacol ; 42: 130-138, 2017 Jan.
Article in En | MEDLINE | ID: mdl-27912149

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Flavonoids / Origanum / Phosphatidylethanolamine Binding Protein / Chemical and Drug Induced Liver Injury / Glycosides / Anti-Inflammatory Agents Type of study: Prognostic_studies Language: En Journal: Int Immunopharmacol Year: 2017 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Flavonoids / Origanum / Phosphatidylethanolamine Binding Protein / Chemical and Drug Induced Liver Injury / Glycosides / Anti-Inflammatory Agents Type of study: Prognostic_studies Language: En Journal: Int Immunopharmacol Year: 2017 Type: Article Affiliation country: China